Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.
Walsh M, Fritz S, Hake D, Son M, Greve S, Jbara M, Chitta S, Fritz B, Miller A, Bader MK, McCollester J, Binz S, Liew-Spilger A, Thomas S, Crepinsek A, Shariff F, Ploplis V, Castellino FJ.
Walsh M, et al.
Curr Drug Targets. 2016;17(8):954-70. doi: 10.2174/1389450117666160310153211.
Curr Drug Targets. 2016.
PMID: 26960340
Free PMC article.
Review.